Commit To Purchase Seres Therapeutics At $7.50, Earn 26.4% Annualized Using Options
June 21, 2018 at 12:04 PM EDT
Investors considering a purchase of Seres Therapeutics Inc (MCRB) shares, but cautious about paying the going market price of $8.95/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $7.50 strike, which has a bid at the time of this writing of 65 cents..